Cipher Pharmaceuticals Inc

SWB:PHE

Business Description

Sector

Health Care

Industry

Pharmaceuticals

Headquarters

Canada CA

Employees

43

IPO date

Feb 25, 2004

Cipher Pharmaceuticals is a specialty drug company that focuses on dermatology and a small number of other prescription products. It does not run a large research lab or a broad drug factory network. Instead, it buys or licenses medicines that already exist or are close to market, then develops, registers, and sells them in the markets where it thinks they can win a place.

The company makes money mainly by selling prescription medicines through pharmacies and healthcare channels, and in some cases by earning royalties or other rights-based income from licensed products. Its main customers are doctors who prescribe the drugs, pharmacies that dispense them, and patients who use them, with hospitals and healthcare distributors also playing a role depending on the product. Cipher’s products are aimed at specific treatment areas, so its business depends more on focused brand building, regulatory approvals, and sales execution than on mass-market consumer demand.

What makes Cipher different is its role as a small, focused commercializer of niche pharmaceutical products. It looks for medicines that can be taken through approval and brought to market without the cost and risk of discovering drugs from scratch. That model can be attractive in specialty medicine because a single approved product can serve a clear medical need and build a durable business if it is well supported by physicians and pharmacists.